XML 55 R45.htm IDEA: XBRL DOCUMENT v3.23.2
Notes Receivable (Details) - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Notes Receivable (Details) [Line Items]    
Principal amount $ 1,800,000  
Accrued interest 250,000  
Interest income 100,000  
Impairment loss $ 0  
Convergent Therapeutics, Inc. Investment [Member]    
Notes Receivable (Details) [Line Items]    
Convertible promissory note percentage 8.00%  
Promissory note maturity date Jan. 29, 2023  
Principal amount $ 1,800,000  
Convergent Therapeutics, Inc. Investment [Member] | Notes Payable [Member]    
Notes Receivable (Details) [Line Items]    
Principal amount 500,000  
Raefan Industries LLC Investment [Member]    
Notes Receivable (Details) [Line Items]    
Interest income receivable 600,000  
Unrealized loss 200,000  
American Innovative Robotics, LLC Investment [Member]    
Notes Receivable (Details) [Line Items]    
Interest income 44,000  
Impairment charges   $ 500,000
Kaya Now Promissory Note [Member]    
Notes Receivable (Details) [Line Items]    
Interest income $ 10,000